ERIC | Projects

General Projects

Establishment and maintenance of information and communication structures on clinical and scientific research of physicians/scientists interested and/or working in the field of CLL

Definition of major/new diagnostic and therapeutic targets in CLL

Creation of and raise of funding for new basic and clinical research projects on CLL

 

Scientific/basic research projects

European wide standardization and future advancement of relevant diagnostic procedures in CLL

  • Standardization & harmonization of cytogenetic/FISH analysis (contact person: Prof. H. Döhner, Ulm/Germany)

  • Standardization & harmonization of MRD diagnostics (minimal residual disease, contact persons: Dr. M. Ritgen, Kiel/Germany, Dr. A. Rawstron, Leeds/Uk, http://www.cll-mrd.org)

  • Standardization & harmonization of cytometric analysis of ZAP70 and CD38 (contact person: Prof. F. Cymbalista, Bobigny/France)
    » more

  • IGHV gene mutational analysis: ERIC consensus recommendations;
    online support for interpretation; collection of "problematic cases"
    (contact persons: Dr. P. Ghia Milan/Italy, Dr. R. Rosenquist, Uppsala/Sweden)
    » more

Collection and evaluation of p53 deleted CLL cases (contact person: Prof. D. Oscier, Bournemouth/UK:  d.oscier@ntlworld.com, p53 Qestionary)

 

Clinical research projects

European survey on current treatment modalities in CLL patients (contact person: Dr. V. Levy, Paris/France:  vincent.levy@sls.ap-hop-paris.fr)

Collection of atypical and familial cases of CLL (contact person: Prof. D. Catovsky, London/UK:  d.catovsky@icr.ac.uk)

Harmonization of common clinical trials on CLL

Evaluation of early treatment versus watch&wait of early stage high risk CLL with FCR (phase III trial of the the French and German CLL study group), (contact: or http://www.dcllsg.de)

Treatment of T-Prolymphocytic Leukemia with Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab (phase II trial), (contact person: Dr. G. Hopfinger, Vienna/Austria)

Erasmus TCRgd LGL study (contact person: Dr. A. W. Langerak, Rotterdam/The Netherlands:  a.langerak@erasmusmc.nl)
» more

EBMT/ERIC recommendations for stem cell transplantation in T cell prolymphocytic leukemia (T-PLL) including criteria for the diagnosis of T-PLL (contact person: Prof. P. Dreger Heidelberg/Germany)
PDF EBMT/ERIC recommendations for SCT in T-PLL